Gossamer Bio, Inc. reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported net loss was USD 55.76 million compared to USD 56.28 million a year ago. Basic loss per share from continuing operations was USD 0.59 compared to USD 0.74 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.605 USD | -2.40% | -8.94% | -33.14% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.14% | 140M | |
+55.59% | 63.85B | |
-1.51% | 41.83B | |
+40.85% | 40.47B | |
-10.02% | 27.17B | |
+13.30% | 26.52B | |
-20.60% | 18.69B | |
+3.01% | 12.73B | |
+22.70% | 12.11B | |
+28.41% | 12.07B |
- Stock Market
- Equities
- GOSS Stock
- News Gossamer Bio, Inc.
- Gossamer Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022